Inspire Medical Systems, Inc. (INSP)
| Market Cap | 1.84B |
| Revenue (ttm) | 911.98M |
| Net Income (ttm) | 145.42M |
| Shares Out | 28.59M |
| EPS (ttm) | 4.89 |
| PE Ratio | 13.19 |
| Forward PE | 31.57 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,642,485 |
| Open | 63.02 |
| Previous Close | 68.05 |
| Day's Range | 62.10 - 65.99 |
| 52-Week Range | 53.11 - 197.75 |
| Beta | 0.72 |
| Analysts | Buy |
| Price Target | 102.86 (+59.45%) |
| Earnings Date | Feb 11, 2026 |
About INSP
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open ai... [Read more]
Financial Performance
In 2025, Inspire Medical Systems's revenue was $911.98 million, an increase of 13.60% compared to the previous year's $802.80 million. Earnings were $145.42 million, an increase of 171.77%.
Financial StatementsAnalyst Forecast
According to 16 analysts, the average rating for INSP stock is "Buy." The 12-month stock price target is $102.86, which is an increase of 59.45% from the latest price.
News
Inspire Medical Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Inspire Medical Systems, Inc. - INSP
NEW YORK and NEW ORLEANS, Feb. 13, 2026 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq.
Inspire Medical: Still A Long Way From A Good Night's Sleep
Inspire Medical Systems faces intensifying competition, reimbursement headwinds, and decelerating growth in the obstructive sleep apnea device market. Despite Q4 revenue and EPS beats, FY26 guidance i...
Inspire Medical Systems, Inc. (INSP) Q4 2025 Earnings Call Transcript
Inspire Medical Systems, Inc. (INSP) Q4 2025 Earnings Call Transcript
Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results
Fourth quarter revenue growth of 12% and full year revenue growth of 14% Fourth quarter net income per diluted share of $4.66; adjusted net income per diluted share of $1.65 Full year net income per d...
The Law Offices of Frank R. Cruz Announces Investigation of Inspire Medical Systems, Inc. (INSP) on Behalf of Investors
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz is investigating potential claims against the board of directors of Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE: INS...
Impulse Dynamics® Announces New Chief Financial Officer
MARLTON, N.J., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Impulse Dynamics®, a global medical device company committed to improving the lives of people with heart failure (HF), announced today the appointment ...
Inspire Medical Systems, Inc. (INSP) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Inspire Medical Systems, Inc. (INSP) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Inspire Medical Systems, Inc. Announces Preliminary Unaudited Revenue Results for the Fourth Quarter and Full Year 2025 and Provides Initial 2026 Revenue Guidance
Inspire Announces Appointment of Matt Osberg as Executive Vice President and Chief Financial Officer Joining the Company in the First Quarter of 2026 Inspire Announces Appointment of Matt Osberg as Ex...
Inspire Medical Systems, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 11, 2026
MINNEAPOLIS, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the fourth quarter and full year 2025 after the close of trading ...
INSP LAWSUIT: Did Inspire Medical Systems, Inc. Mislead Investors? Contact BFA Law by January 5 Legal Deadline if You Suffered Losses
NEW YORK, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Leading international securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Inspire Medical Systems, I...
Inspire Medical Systems, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference
MINNEAPOLIS, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minima...
INSP REMINDER: Inspire Medical Systems, Inc. Investors are Alerted of the Imminent January 5 Deadline and to Contact BFA Law if You Lost Money
New York, New York--(Newsfile Corp. - December 28, 2025) - Leading international securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Inspire Med...
Inspire Medical Systems, Inc. (INSP) Investors are Notified that Company has been Sued for Securities Fraud after 32% Stock Drop and are Urged to Contact BFA Law
New York, New York--(Newsfile Corp. - December 26, 2025) - Leading international securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Inspire Med...
Inspire Medical (INSP) Crashes Over 32%, “Inspire V” Launch Failure, Hagens Berman Urges Investors with Losses to Contact Firm by Jan. 5
SAN FRANCISCO, Dec. 25, 2025 (GLOBE NEWSWIRE) -- National investor rights law firm Hagens Berman alerts INSP investors to the pending securities class action lawsuit against Inspire Medical Systems, I...
INSP INVESTOR LOSSES: Inspire Medical Systems, Inc. Investors May have been Affected by Fraud – Contact BFA Law by January 5 to Protect Your Rights
NEW YORK, Dec. 25, 2025 (GLOBE NEWSWIRE) -- Leading international securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Inspire Medical Systems, ...
INSP INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Inspire Medical Systems
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses in Inspire Medical to Contact Him Directly to Discuss Their Options If you purchased or ...
INSP COURT REMINDER: Inspire Medical Systems, Inc. Securities Fraud Deadline Approaching – Contact BFA Law before January 5
NEW YORK, Dec. 21, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Inspire Medical Systems, Inc. (NYSE: IN...
INSP LEGAL NOTICE: Lose Money on Inspire Medical Systems, Inc.? You may have been Affected by Fraud and are Urged to Contact BFA Law by January 5 Deadline
NEW YORK, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Inspire Medical Systems, Inc. (NYSE: INS...
Inspire Medical (INSP) Crashes Over 32%, "Inspire V" Launch Failure, Hagens Berman Urges Investors with Losses to Contact Firm by Jan. 5
Partner Reed Kathrein Scrutinizing Alleged Concealment of Billing Code Errors and Inventory Glut Driving 80% Guidance Cut SAN FRANCISCO , Dec. 17, 2025 /PRNewswire/ -- National shareholder rights law ...
UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Inspire Medical Systems
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses in Inspire Medical to Contact Him Directly to Discuss Their Options If you purchased or ...
AMG Frontier Small Cap Growth Fund: Q3 Sees Strong Outperformance Across Semiconductor Holdings
Our portfolios underperformed during the quarter and trail year to date. Health care was the primary hindrance as a result of our underweight in biotech and negative stock selection. We have materiall...
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Inspire Medical Systems
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Inspire Medical To Contact Him Directly To Discuss Their Options
Shareholders who lost money in shares of Inspire Medical Systems, Inc. (NYSE: INSP) Should Contact Wolf Haldenstein Immediately
Lead Plaintiff Deadline is January 5, 2026 NEW YORK , Dec. 8, 2025 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP informs investors in Inspire Medical Systems, Inc. (NYSE: INSP) ("Inspire")...
Inspire Medical Systems, Inc. (INSP) Investors are Encouraged to Act before the Upcoming January 5 Securities Fraud Deadline – Contact BFA Law if You Lost Money
NEW YORK, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Inspire Medical Systems, Inc. (NYSE: IN...
INSP LAWSUIT DEADLINE: Hagens Berman Urges Inspire Medical Investors to Act by Jan. 5 Over 32% Crash and “Inspire V” Launch Failure
Partner Reed Kathrein Scrutinizing Alleged Concealment of Billing Code Errors and Inventory Glut Driving 80% Guidance Cut Partner Reed Kathrein Scrutinizing Alleged Concealment of Billing Code Errors ...